Sentinel node biopsyAxillary stagingAxillary lymph node dissectionBreast cancerSince only a small percentage of patients with operable breast cancer will be found to have involved axillary nodes, conventional axillary lymph node dissection (ALND), which is associated with unjustifiably high morbidity, is'...
Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care A sentinel lymph node is the first lymph node to receive lymphatic drainage from a tumor. It can be detected by injection of a blue dye or radioactive colloid around the primary tumor, which travels to and ...
Performing a sentinel lymph node biopsy (SLNB) is the standard of care for axillary nodal staging in patients with invasive breast cancer and clinically negative nodes. The procedure provides valuable staging information with few complications when performed by experienced surgeons. However, variation in...
Recent data indicates that the sentinel lymph node biopsy (SLNB) is a possible alternative to axillary lymph node dissection (ALND) in early breast cancer patients, with minimal risk of complications. From the medical oncologist's point of view, the impact of SLNB on the management of patients...
The Lymphatic Anatomy of the Breast and its Implications for Sentinel Lymph Node Biopsy: A Human Cadaver Study Current understanding of the lymphatic system of the breast is derived mainly from the work of the anatomist Sappey in the 1850s, with many observations ma... S Hiroo,WR Pan,G Mann...
Objective To investigate the effect of sentinel lymph node biopsy on the operation of early breast cancer patients. Methods Forty-eight patients with early primary breast cancer admitted to our hospital from January 2014 to March 2019 were enrolled. Ac-cording to the surgical procedure, the patients...
Objective Sentinel lymph node biopsy (SLN) using blue dye and radioisotope is a widely used tool in the staging of breast cancer. However, multiple SLNs are frequently found. We sought to determine whether there is safe number of SLNs at which to stop the procedure without affecting accuracy...
Background The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was designed to evaluate a specific algorithm for timing of a standardised sentinel-lymph-node biopsy procedure in patients ...
Sentinel lymph node biopsy (SLNB) was introduced 2 decades ago and thereafter validated for routine surgical management of breast cancer, including cases treated with neoadjuvant chemotherapy. As the number of lymph nodes for staging has decreased, pathologists have scrutinized SLN with a combination of...
摘要: Recent data indicates that the sentinel lymph node biopsy (SLNB) is a possible alternative to axillary lymph node dissection (ALND) in early breast cancer patients, with minimal risk of complications.关键词: breast neoplasms sentinel lymph node ...